01:55 PM EDT, 05/24/2022 (MT Newswires) -- HilleVax (HLVX) shares were up 9% by Tuesday afternoon after four brokerages started coverage of the biopharmaceutical company.
美国东部时间2022年5月24日下午01：55(MT Newswres)--在四家券商开始报道生物制药公司HilleVax后，截至周二下午，HilleVax(HLVX)的股价上涨了9%。
Stifel began coverage at buy with a $34 price target, JPMorgan at overweight with a $24 price target, Guggenheim at buy with a $40 price target and SVB Securities at outperform with a $30 price target.
Stifel在Buy的目标价为34美元，摩根大通在增持的目标价为24美元，Guggenheim在Buy的目标价为40美元，SVB Securities的目标价为30美元，强于大盘。
Price: 10.18, Change: +0.68, Percent Change: +7.11
价格：10.18，变化：+0.68，变化百分比：+7.11